- Home
- SILO vs BJDX Comparison
SILO vs BJDX Comparison
Compare SILO & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- BJDX
- Stock Information
- Founded
- SILO 2010
- BJDX 2015
- Country
- SILO United States
- BJDX United States
- Employees
- SILO N/A
- BJDX N/A
- Industry
- SILO Apparel
- BJDX Medical Specialities
- Sector
- SILO Consumer Discretionary
- BJDX Health Care
- Exchange
- SILO Nasdaq
- BJDX Nasdaq
- Market Cap
- SILO 3.1M
- BJDX 2.9M
- IPO Year
- SILO N/A
- BJDX 2021
- Fundamental
- Price
- SILO $0.58
- BJDX $2.25
- Analyst Decision
- SILO
- BJDX
- Analyst Count
- SILO 0
- BJDX 0
- Target Price
- SILO N/A
- BJDX N/A
- AVG Volume (30 Days)
- SILO 2.4M
- BJDX 2.0M
- Earning Date
- SILO 05-09-2025
- BJDX 05-13-2025
- Dividend Yield
- SILO N/A
- BJDX N/A
- EPS Growth
- SILO N/A
- BJDX N/A
- EPS
- SILO N/A
- BJDX N/A
- Revenue
- SILO $72,102.00
- BJDX N/A
- Revenue This Year
- SILO $1.86
- BJDX N/A
- Revenue Next Year
- SILO N/A
- BJDX $55.56
- P/E Ratio
- SILO N/A
- BJDX N/A
- Revenue Growth
- SILO N/A
- BJDX N/A
- 52 Week Low
- SILO $0.41
- BJDX $1.46
- 52 Week High
- SILO $4.50
- BJDX $236.00
- Technical
- Relative Strength Index (RSI)
- SILO 45.16
- BJDX 58.09
- Support Level
- SILO $0.43
- BJDX $1.49
- Resistance Level
- SILO $0.49
- BJDX $1.82
- Average True Range (ATR)
- SILO 0.06
- BJDX 0.18
- MACD
- SILO 0.03
- BJDX 0.07
- Stochastic Oscillator
- SILO 45.03
- BJDX 79.17
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.